heart attack Archives
LifeFlight personnel train on advanced cardiac devices
Jan. 19, 2023—Vanderbilt LifeFlight personnel recently received training on using advanced cardiac devices in transport settings, devices that were historically found only at hospitals like VUMC.
Sex & race & door-to-ECG time
Jun. 2, 2022—More than a third of patients presenting at the emergency department with a suspected heart attack have a “delayed” ECG measure of heart function, with Black patients, females and non-English speakers more likely to experience delays.
Polymer protection for heart muscle
Dec. 14, 2020—Vanderbilt researchers demonstrate that the polymer P188 has promise as a therapy to prevent reperfusion injury — the cellular damage that occurs when blood flow returns after an ischemic event like a heart attack.
Article examines need for genotyping after stenting
Oct. 24, 2019—Genotyping can improve outcomes in patients who require anti-platelet therapy following stent placement to open narrowed or blocked coronary arteries and prevent a heart attack.
Less inflammation = better healing
Oct. 17, 2019—Immune cells that produce an anti-inflammatory factor are enriched in fat tissue around the heart and may be good targets to improve heart attack outcomes.
Novel genetic study sheds new light on risk of heart attack
Oct. 11, 2018—Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife.
Gene study spots clues to heart risk for statin patients
May. 3, 2018—A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol.
Report calls for greater awareness of rare cardiac disease
Apr. 5, 2018—A national effort seeks to raise awareness about an uncommon cause of heart attacks in otherwise healthy, young and middle-aged women.
Cancer immunotherapy drugs linked with more serious heart effects
Mar. 12, 2018—Vanderbilt University Medical Center investigators have identified a growing number of serious and sometimes fatal cases of heart problems among cancer patients treated with some forms of immunotherapy.
New clinic focuses on treating complex arterial disorders
Feb. 23, 2017—When Jessica Biggs first met Esther Kim, M.D., associate professor of Medicine at Vanderbilt, the 33-year-old burst into tears.
Going after the ‘heart attack gremlin’
Sep. 8, 2016—A protein called Gremlin 2 controls the extent of inflammation after heart attack and may be a good therapeutic target.
Uninsured heart attack patients more likely to be transferred to another facility: study
Jun. 9, 2016—A new study finds that uninsured heart attack patients are more likely to be transferred.
